Essex Property Trust, Inc. vs Revvity Inc — how do they compare? Essex Property Trust, Inc. trades at $282.11 (market cap $18.15B), while Revvity Inc trades at $117.6 (market cap $12.91B). The key difference: Essex Property Trust, Inc. is the larger of the two by market cap, and Essex Property Trust, Inc. pays the higher dividend (3.93%). Which is the better fit depends on your goals.
| ESS | RVTY | |
|---|---|---|
Market Cap | $18.15B | $12.91B |
Sector | Real Estate | Technology |
52-Week High | $298.33 | $117.75 |
52-Week Low | $239.61 | $82.26 |
Enterprise Value | $24.75B | $15.23B |
Dividend Yield | 3.93% | 0.24% |
Signals from Pluang's Aura AI — not financial advice
ESS trades at $281.27, down 0.69% on the day, with a bearish technical signal. The company reported a Q2 2026 EPS miss ($0.97 vs. $1.46 expected) but raised full-year FFO guidance. Revenue grew to $1.89B in 2025, with a strong net income margin of 35.48%, though profitability is projected to moderate in 2026. The stock is supported by a $2.59 dividend and a consensus price target of $305.86, implying potential upside.
The outlook is mixed: raised guidance and institutional buying signal confidence, but technical weakness and a high debt load pose risks. The stock offers income and growth potential if operational execution improves, yet faces headwinds from regional market softness and interest rate sensitivity.
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
Trailing returns across standard periods
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →